Do you suffer from high blood pressure? Garlic as a natural remedy: what research confirms

Updated and contextualized version of an article originally published on June 6, 2014
The article retains its original focus by presenting it through a scholarly and accessible perspective, supported by verifiable references.

Authors

• Dr. M. Mondini – Biologist
• Roberto Panzironi –Independent researcher 

Note editoriali

• First publication: June 6, 2014
• Last update: April 18, 2026
• Version: 2026 narrative revision  

In brief

• Garlic has been associated with modest but consistent reductions in blood pressure in hypertensive individuals.
• Most evidence comes from standardized supplements (aged extracts, sustained-release powders) rather than occasional consumption of raw garlic.
• Effects vary greatly depending on the form, dose, and study group; not all people respond.
• There are plausible biological mechanisms (vasodilation, modulation of NO/H2S and enzymatic activity), but proof of benefit on cardiovascular events is not consolidated.
• Before using garlic-based supplements, it is important to assess safety and possible drug interactions with your doctor.

Abstract: what does science say?

Garlic (Allium sativum) has been the subject of numerous clinical studies and meta-analyses for its potential hypotensive effect. In populations with hypertension, aggregated reviews report average reductions in systolic and diastolic blood pressure that, in many trials, are in the order of a few millimeters of mercury. The most consistent studies use standardized forms of supplementation (aged extracts, controlled-release powders) and varying treatment durations (weeks-months). The evidence shows a favorable but heterogeneous picture: some trials and meta-analyses indicate clinically relevant effects in hypertensive subjects, while others find more modest or non-uniform reductions. Uncertainties remain regarding dose-effect, optimal duration, type of preparation, and impact on long-term clinical outcomes. Therefore, garlic can be considered a possible complementary option, not a substitute therapy for proven pharmacological treatments.

What it means in practice

For those living with high blood pressure, available scientific evidence suggests that some garlic-based preparations may help reduce blood pressure values, particularly in the already hypertensive population. Meta-analyses and systematic reviews show average effects that, while varying between studies, are often clinically relevant in subjects with high baseline values. However, not all trials agree: the extent and consistency of the reduction depend on factors such as the form of garlic used (aged extract, delayed-release powder, oil), the daily dose, the duration of treatment, and the characteristics of the participants [1][2].

This means that the use of garlic as a supplement can be evaluated as part of a broader approach (diet, physical activity, weight control, adherence to pharmacological therapies when indicated). It should not be considered an automatic alternative to antihypertensive drugs prescribed by a doctor, especially in cases of moderate-to-severe hypertension or with additional risk factors. Furthermore, the effect is subjective: some patients are "responders," while others show no appreciable change [3][4][5].

Plausible biological mechanisms

The hypotensive properties attributed to garlic have credible biological bases. Non-volatile sulfur compounds (e.g., S-allylcysteine in aged extracts) and enzymatic reaction products (allicin and derivatives) can promote vasodilation through increased local production of nitric oxide (NO) and hydrogen sulfide (H2S), in addition to modulating enzymes involved in the renin-angiotensin system. These mechanisms have been observed in preclinical studies and discussed in clinical reviews, offering a plausible explanation for the reduction in peripheral vascular resistance and the decrease in blood pressure reported in some trials [4][1].

What forms of garlic and what doses have been studied?

Clinical literature uses different preparations: aged garlic extract (AGE), standardized garlic powders (e.g., Kwai, Allicor), and controlled-release formulations. The effective dosages observed in trials vary: for example, aged extracts have been tested in ranges such as 240–960 mg/day (with specific S-allylcysteine content) in 12-week trials [4], while controlled-release powders have been studied at around 600 mg/day [7]. More recent meta-analyses collect studies with doses between a few hundred and over 2,000 mg/day, with effects sometimes proportional to the form and population studied [8].

Safety, interactions, and contraindications

Overall, garlic-based supplements are well-tolerated in clinical trials, but they are not without risks. Garlic can increase the risk of bleeding in people taking anticoagulants or antiplatelet drugs and can interact with drugs metabolized by liver enzymes; furthermore, consuming raw garlic often causes bad breath and gastrointestinal upset. Studies evaluating aged extracts indicate favorable tolerability profiles, but long-term safety and safety in people with significant comorbidities require clinical attention [1][5][9].

Key takeaways

• Garlic has shown the ability to reduce blood pressure in several clinical studies, especially in subjects who are already hypertensive.
• The most studied forms are aged extracts and standardized powders; the type and dose influence the effect.
• The effect is not universal: individual response and variability among studies are high.
• Garlic can interact with medications (anticoagulants, some antihypertensives) and should be evaluated by a doctor.
• Do not replace prescribed therapy: consider garlic as a possible complement after consulting with a healthcare professional.

Limitations of the Evidence

The available evidence presents methodological and interpretative limitations. Many trials have small sample sizes, short durations, and significant differences in the preparation and standardization of the tested product; this generates heterogeneity in results and makes it difficult to establish an optimal standard dose [2][3]. Several meta-analyses show more marked blood pressure reductions in hypertensive subgroups compared to normotensive subjects, indicating that the effect strongly depends on the initial blood pressure level [1][3].

Another limitation is the scarcity of data on long-term clinical outcomes (heart attack, stroke, mortality): most of the evidence concerns the reduction of blood pressure values in the short-to-medium term, not the prevention of cardiovascular events. Furthermore, the presence of possible publication bias and funding linked to supplement manufacturers has been discussed in the literature and requires caution in interpretation [1][2]. Finally, there are differences between observational studies (which report associations) and randomized controlled trials (which test causal effects): the former are useful for hypotheses, while the latter are necessary for inferences of efficacy; the literature on the topic is more robust for RCTs but not yet definitive for general clinical recommendations [2][8].

Editorial Conclusion

Overall, scientific evidence suggests that some garlic preparations may help reduce blood pressure in people with hypertension, but the effect is variable and conditioned by form, dose, duration, and patient characteristics. Garlic does not replace validated antihypertensive therapies, and there is insufficient evidence to recommend it as an alternative treatment for all patients. Instead, it can be considered, with caution and under medical supervision, as part of an integrated approach to blood pressure management. Larger, longer-term, and independent studies are needed to clarify the dose-response relationship, long-term safety, and impact on clinically important cardiovascular outcomes.

SCIENTIFIC RESEARCH

List of cited sources (order of appearance). Each entry includes a clickable, verified DOI for direct consultation.

1. Ried K. Garlic lowers blood pressure in hypertensive individuals, regulates serum cholesterol, and stimulates immunity: An updated meta-analysis and review. J Nutr. 2016;146(2):389S–396S. https://doi.org/10.3945/jn.114.202192
2. Rohner A, Ried K, Sobenin IA, Bucher HC, Nordmann AJ. A systematic review and metaanalysis on the effects of garlic preparations on blood pressure in individuals with hypertension. Am J Hypertens. 2015;28(3):414–423. https://doi.org/10.1093/ajh/hpu165
3. Reinhart KM, Coleman CI, Teevan C, Vachhani P, White CM. Effects of garlic on blood pressure in patients with and without systolic hypertension: a meta-analysis. Ann Pharmacother. 2008;42(12):1766–1771. https://doi.org/10.1345/aph.1L319
4. Ried K, Frank OR, Stocks NP. Aged garlic extract reduces blood pressure in hypertensives: a dose–response trial. Eur J Clin Nutr. 2013;67:64–70. https://doi.org/10.1038/ejcn.2012.178
5. Ried K, Fakler P, Sullivan T, et al. Aged garlic extract lowers blood pressure in patients with treated but uncontrolled hypertension: a randomised controlled trial. Maturitas. 2010;67(2):144–150. https://doi.org/10.1016/j.maturitas.2010.06.001
6. Nakasone Y, Nakamura Y, Yamamoto T, Yamaguchi H. Effect of a traditional Japanese garlic preparation on blood pressure in prehypertensive and mildly hypertensive adults. Exp Ther Med. 2013;5(2):399–405. https://doi.org/10.3892/etm.2012.819
7. Sobenin IA, Andrianova IV, Fomchenkov IV, et al. Time-released garlic powder tablets lower systolic and diastolic blood pressure in men with mild and moderate arterial hypertension. Hypertens Res. 2009;32:433–437. https://doi.org/10.1038/hr.2009.36
8. Wang Q, Zhang T, Liu T, et al. Effects of garlic supplementation on components of metabolic syndrome: a systematic review, meta-analysis, and meta-regression of randomized controlled trials. BMC Complement Med Ther. 2023. https://doi.org/10.1186/s12906-023-04038-0
9. Antihypertensive Effects of an Optimized Aged Garlic Extract in Subjects with Grade I Hypertension and Antihypertensive Drug Therapy: A Randomized, Triple-Blind Controlled Trial. Nutrients. 2023;15(17):3691. https://doi.org/10.3390/nu15173691

Final check: all listed DOIs were verified and are resolvable at the time of this article's update.